AVEO Pharmaceuticals (AVEO) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q2 EPS of ($0.10), $0.10 better than the analyst estimate of ($0.20).
For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
